Tumor progression: a brief historical perspective.

[1]  Theodor Boveri.  Zur Frage der Entstehung maligner Tumoren , 1914 .

[2]  L. R. Foulds,et al.  Tumor Progression: Guest Editorial , 1957 .

[3]  P. Nowell,et al.  A minute chromosome in human chronic granulocytic leukemia , 1960 .

[4]  P. Nowell,et al.  Radiation carcinogenesis: the sequence of events. , 1965, Science.

[5]  F. Burnet.  The concept of immunological surveillance. , 1970, Progress in experimental tumor research.

[6]  John Cairns,et al.  Mutation selection and the natural history of cancer , 1975, Nature.

[7]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[8]  G. Klein.  Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Rowley,et al.  Chromosome abnormalities in malignant hematologic diseases. , 1982, Advances in cancer research.

[10]  P. Nowell.  Cytogenetics of preleukemia. , 1982, Cancer genetics and cytogenetics.

[11]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[12]  A. Maizel,et al.  Mediators in cell growth and differentiation. , 1984, Symposium on Fundamental Cancer Research.

[13]  J. Westin,et al.  Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression. , 1985, Cancer genetics and cytogenetics.

[14]  C. Turc‐Carel,et al.  The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology , 1987, Cancer.

[15]  P. Nowell,et al.  Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[17]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[18]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[19]  Myriam Alcalay,et al.  The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.

[20]  R. Weinberg.  The Molecular Basis of Oncogenes and Tumor Suppressor Genes , 1995, Annals of the New York Academy of Sciences.

[21]  P. Pandolfi.  PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia. , 1996, Haematologica.

[22]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[23]  Wyllie Ah.  Apoptosis and carcinogenesis. , 1997 .

[24]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[25]  M. Barinaga.  Designing Therapies That Target Tumor Blood Vessels , 1997, Science.

[26]  C. Verfaillie,et al.  Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors? , 1997, Acta haematologica.

[27]  Ronald A. DePinho,et al.  The age of cancer , 2000, Nature.

[28]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[29]  J. Yokota,et al.  Tumor progression and metastasis. , 2000, Carcinogenesis.

[30]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[31]  L. Loeb,et al.  A mutator phenotype in cancer. , 2001, Cancer research.

[32]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[33]  J. Marx.  Do Centrosome Abnormalities Lead to Cancer? , 2001, Science.